Alvogen is voluntarily recalling two lots of Fentanyl Transdermal 12 mcg/h Patches distributed starting on April 19, 2019. The Food and Drug Administration (FDA) classified this recall as a Class I Recall on May 15, 2019.

The maker is recalling Fentanyl 12 mcg/h patches because they are mislabeled and instead contain the 50 mcg/h dose. To date, no harmful side effects have been reported due to this recall

We want you to get the information you need to take care of your health. Please visit https://alvogen.com/newsroom/alvogen-inc-issues-voluntary-nationwide-recall-of-fentanyl-transdermal for more information. You can also call the FDA toll free at 1-888-INFO-FDA (1-888-463-6332) (TTY 711 ) or the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711 ).